Trials / Completed
CompletedNCT02530970
A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope
A Post Market Observational Study to Obtain Additional Information on the Use of Cormatrix® Cangaroo ECM® Envelope
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,025 (actual)
- Sponsor
- Elutia Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of the SECURE Study is to actively gather additional information on the use of the CorMatrix® CanGaroo ECM® Envelope in a post market observational study.
Conditions
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-12-01
- Completion
- 2018-04-01
- First posted
- 2015-08-21
- Last updated
- 2023-07-21
- Results posted
- 2020-03-11
Locations
39 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02530970. Inclusion in this directory is not an endorsement.